Biotechnology

Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal

Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?

FDA Rejects ImmunityBio's Bladder Cancer Therapy Filing

Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?

FDA Rejects ImmunityBio's Bladder Cancer Therapy Filing

Virios Therapeutics Up 75% On Fibromyalgia Phase 3 Proposal

After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade

Virios Therapeutics Up 75% On Fibromyalgia Phase 3 Proposal

|

After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade

|

Junior Biotech Stocks Outperforming In An Already Buoyant Market

Sponsored

Janney Upgrades bluebird bio Ahead Of Sickle Cell Presentation

|

Biotechnology Recent News

Equillium's IPO: What You Need To Know

|

Dicerna Pharma Has Multiple Pipeline Opportunities, Tough Competition, Analyst Says In Neutral Initiation

|

Turning Neutral: Morgan Stanley Downgrades Sarepta, Loxo Oncology, Global Blood Therapeutics

|

William Blair: Bluebird Bio Could See Another 'Blue Ribbon Year' In 2018

|

BofA: The Biotech Sector Is In A 'Perfect Storm' For M&A

|

It's A Bad Day For Biotechs

|

Analyst Sees 243% Upside For Corbus Pharma Following Positive Clinical Data

|

Endocyte Shares Up More Than 100% In 2 Days, But Analyst Sees Even More Upside Possible

|

3 Reasons To Like Vertex Pharma Shares

|

Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead

|

Analyst Makes The Case For Ligand As A 'Core' Holding

|

3 Things Deutsche Bank Likes About Agilent's Q3, And One Thing To Be Cautious Of

|

Cramer: Small-Cap Biotechs Are Reserved For Speculative Investors

|

Cyclacel Pharmaceuticals' 35% Spike: Manipulation Or Something Else?

|

A Bull Call On A Marquee Healthcare ETF

|

6 Biotechs Still Awaiting December Catalysts

|

These Biotechs Are Getting Crushed Following Juno's Cancer Drug Hold

|

This Biotech ETF Could Be Ready To Party

|

Here's Why Prima BioMed Is Up 15%

|

4 Companies Pfizer Just Increased Its Stake In

|

Shares Of Chimerix Higher By Nearly 6% After Point72 Stake Reveal

|

Vetr Crowd No Longer Uber-Bearish On Puma Biotech

|

15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference

|